The class of chemicals known as Olfr779 Inhibitors encompasses a diverse array of compounds that demonstrate the ability to interfere with the activity of the olfactory receptor protein Olfr779. These inhibitors are not unified by a common chemical structure or origin but are categorized based on their functional impact on Olfr779. The inhibitory action can arise through various mechanisms, such as blocking the receptor's active site, altering the receptor's conformation, disrupting G-protein coupling and signal transduction, or by modulating the receptor's cellular environment in a way that affects its ability to respond to its natural ligands. The complexity of these mechanisms reflects the intricate nature of olfactory signal transduction, a process that involves the initial binding of odorant molecules to olfactory receptors, followed by a cascade of intracellular events leading to a neural response.
Within this group, some inhibitors act directly on the Olfr779 receptor, binding to it in a manner that prevents odorant molecules from interacting with the receptor. Others exert their effects indirectly by targeting downstream elements of the olfactory signal transduction pathway. For instance, some inhibitors might reduce the levels of intracellular second messengers that are essential for propagating the signal from the receptor to the olfactory bulb in the brain. Alternatively, certain molecules within this class may inhibit the function of ion channels that play a crucial role in the generation of the electrical signal that constitutes the neural response to an odor. The ion channel inhibitors, for instance, might block the channels that allow ions to flow into olfactory sensory neurons, which is a vital step in olfactory perception.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Methyllycaconitine citrate | 112825-05-5 | sc-253043 sc-253043A | 5 mg 25 mg | $117.00 $398.00 | 2 | |
Inhibits neuronal nicotinic acetylcholine receptors, reducing the sensitivity of olfactory sensory neurons. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $442.00 | 3 | |
Inactivates Gi/o type G-proteins, inhibiting their interaction with olfactory receptors and subsequent signaling. | ||||||
Carvedilol | 72956-09-3 | sc-200157 sc-200157A sc-200157B sc-200157C sc-200157D | 100 mg 1 g 10 g 25 g 100 g | $122.00 $235.00 $520.00 $979.00 $1500.00 | 2 | |
Blocks beta-adrenergic and alpha-1 receptors, reducing cAMP levels and inhibiting olfactory receptor signaling. | ||||||
SQ 22536 | 17318-31-9 | sc-201572 sc-201572A | 5 mg 25 mg | $93.00 $356.00 | 13 | |
Inhibits adenylate cyclase, preventing the production of cAMP, a crucial second messenger in olfactory signal transduction. | ||||||
SCH 23390 | 125941-87-9 | sc-200408 sc-200408A | 5 mg 25 mg | $175.00 $719.00 | 2 | |
Blocks dopamine D1 receptors, inhibiting dopaminergic modulation of olfactory signal transduction. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $90.00 $350.00 | 16 | |
Inhibits phosphodiesterase type 3, leading to increased cAMP levels that result in olfactory receptor desensitization. | ||||||
KT 5720 | 108068-98-0 | sc-3538 sc-3538A sc-3538B | 50 µg 100 µg 500 µg | $97.00 $144.00 $648.00 | 47 | |
Inhibits protein kinase A, preventing phosphorylation events crucial for olfactory receptor signaling. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $449.00 | 61 | |
Chelates intracellular Ca2+, inhibiting calcium-dependent processes in olfactory signal transduction. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Inhibits SERCA, disrupting Ca2+ stores and thereby inhibiting calcium-regulated components of olfactory signaling. | ||||||